cinnamoyl hydrazide

Cinnamic acid, hydrazide is an unsaturated carboxylic acid and precursor to aspartame via enzyme-catalysed amination to phenylalanine. Cinnamic acid may be useful in prevention or treatment of Diabetes through various mechanism of actions including stimulation of insulin secretion, improvement of pancreatic β-cell functionality, inhibition of hepatic gluconeogenesis, enhanced glucose uptake, increased insulin signaling pathway, delay of carbohydrate digestion and glucose absorption, and inhibition of protein glycation and insulin fibrillation.

Cinnamic acid-D6 is the deuterated form of Cinnamic acid (T5646). It shows potential applications in cancer treatment, with IC50 values ranging from 1 to 4.5 mM for glioblastoma, melanoma, prostate cancer, and lung cancer cells.

Cinnamic acid (β-Phenylacrylic acid) has potential use in cancer intervention,The concentration causing a 50% reduction of cell proliferation (IC50) ranged from 1 to 4.5 mM in glioblastoma, melanoma, prostate and lung carcinoma cells.

trans-Cinnamic acid (Myricitrine) exerts anti-diabetic activity by improving glucose tolerance in vivo and by stimulating insulin secretion in vitro.

trans-Cinnamic acid-D7 is the deuterated form of trans-Cinnamic acid (TMSM-2714). This compound functions as a fungicide with a minimum inhibitory concentration (MIC) of 250 μg/mL against the fish pathogen Aeromonas sobria (A. sobria, SY-AS1).

Sodium cinnamate, a naturally occurring low-toxicity aromatic fatty acid with oral activity, exhibits neuroprotective and anti-inflammatory properties.

trans-Cinnamic acid (Standard) is a reference standard for research and analysis in studies involving trans-Cinnamic acid. trans-Cinnamic acid (Myricitrine) exerts anti-diabetic activity by improving glucose tolerance in vivo and by stimulating insulin secretion in vitro.

Cinnamic acid-13C3 is the 13C labeled variant of cinnamic acid (T5646), which is potentially useful in cancer treatment. It has demonstrated IC50 values ranging from 1 to 4.5 mM against glioblastoma, melanoma, prostate, and lung cancer cells.